格隆汇2月6日丨俊裕地基(01757.HK)公告，因应中国民众消费水平提升及人口老化趋势，集团将积极配 合国家政策，计划于中国开展新业务，重点发展两大连锁产业：(i)医学美容；及(ii)健康养生(「新业 务」)。 在医学美容领域方面，集团拟集中发展医学美容业务，包括整合全国顶尖医疗专家团队、设立高端医学 美容医院，并与再生医学机构建立合作关系。集团旨在打造全面且专业的医学美容生态体系。 在健康养生领域方面，集团拟发展健康养生产业的布局。建议计划包括建立全国性健康养生连锁店网 络、发挥店舖集群优势，并强化整体产业链上下游以形成闭环生态体系。 集团将积极探索产业链的纵向延伸与横向协作。透过战略投资、业务合作及并购，集团拟连系医学美容 与健康养生领域的更多夥伴与资源，旨在构建开放、协作、互利互惠的产业生态平台，为两大连锁产业 培育新的增长曲线。 ...

Group 1 - Xiamen Tungsten announced an investment of 388 million yuan to establish a wholly-owned subsidiary, Xiamen Jinlu Advanced Ceramic Materials Co., Ltd., in Huli District to expand into new business areas [1] - The registered capital of the new subsidiary is 190 million yuan, with a fixed asset investment of 358 million yuan and working capital of 30.05 million yuan, all funded by the company [1] - The project is expected to take three years to complete and will serve as a comprehensive platform for Xiamen Jinlu's overall solution development services, showcasing efficient cutting solutions and rapid production capabilities [1] Group 2 - Xinha shares recently established Xiamen Xinshi Intelligent Investment Information Technology Co., Ltd., focusing on artificial intelligence application software development and network security software development [2] - Last year, Xinha invested 100 million yuan to set up Xiamen Xinha Tengying Investment Co., Ltd., targeting low-altitude economy, artificial intelligence, and new technology innovation [2] - In May of this year, Xinha invested 20 million yuan to establish a wholly-owned subsidiary in Shanghai to support its main business development and expand its business layout [2] Group 3 - Luyuan Pharmaceutical announced an investment of approximately 600 million yuan through its wholly-owned subsidiary Luyuan Jiawen to build two hotels and incubate health-related businesses [3] - The investment aims to extend the value chain of health services, including medical rehabilitation, health maintenance, elderly leisure, sports, and cultural tourism [3] - Luyuan Jiawen plans to establish two hotel management companies with its own funds and introduce an internationally renowned hotel brand (Hilton) and management team for daily operations [3]

Core Viewpoint - Luyuan Pharmaceutical (002788) plans to invest approximately 600 million yuan in the construction of two hotels, partnering with Hilton for management and branding, aiming to enhance its healthcare service ecosystem [1] Group 1: Investment and Development - The company’s wholly-owned subsidiary, Luyuan Jiawen (Xiamen) Investment Development Co., Ltd., will oversee the hotel projects [1] - The investment will focus on creating hotels that offer differentiated competitive advantages, supporting the company's healthcare and wellness initiatives [1] - The hotels will serve as a hub to incubate related businesses in medical rehabilitation, health maintenance, elderly care, sports, and cultural tourism [1] Group 2: Management and Branding - Hilton Enterprises Management (Shanghai) Co., Ltd. has been contracted for the management and branding of the hotels under the "Hilton" and "Tempo by Hilton" brands [1] - The collaboration with Hilton is expected to enhance the brand image and long-term development of the projects [1] Group 3: Financial Structure - To facilitate the operation of the hotel projects, Luyuan Jiawen will establish two wholly-owned subsidiaries with registered capital of 10 million yuan and 20 million yuan respectively [1]